Published online before print July 28, 2003, doi: 10.1161/01.HYP.0000085857.95253.79
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;42:257.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
Volume Status and Blood Pressure During Long-Term Hemodialysis
Role of Ventricular Stiffness
From the Department of Medicine, Taipei Veterans General Hospital, and the Department of Social Medicine, National Yang-Ming University, Taipei, Taiwan.
Reprint requests to Chen-Huan Chen, MD, 201 Shih-Pai Rd, Sec 2, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. E-mail chench{at}vghtpe.gov.tw
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
The importance of volume status on blood pressure in hemodialysis patients has long been recognized. We hypothesized that the enhanced volume dependency of blood pressure is partly determined by ventricular stiffness at end systole. A total of 115 long-term hemodialysis patients were invited to receive a comprehensive, noninvasive cardiovascular examination. End-systolic elastance was determined by using a novel, noninvasive echo-Doppler technique. The positive ratios of the interdialytic systolic blood pressure change vs weight gain during the subsequent 25 hemodialysis sessions were averaged to obtain the volume sensitivity index (mm Hg/kg). The averaged interdialytic weight gain per fat-free mass was correlated significantly with averaged percent change in systolic blood pressure (r=0.45, P<0.001). The estimated end-systolic elastance at baseline was significantly correlated with subsequently observed volume sensitivity index (volume sensitivity index=[1.17xend-systolic elastance]+6.4; r=0.34, P=0.001). End-systolic elastance was also significantly correlated with various vascular function parameters, including effective arterial elastance (r=0.48, P<0.001), pulse wave velocity (r=0.30, P=0.001), carotid augmentation index (r=0.31, P<0.001), and aortic compliance (r=-0.49, P<0.001). The results suggest that end-systolic elastance, a direct measure of left ventricular mechanical properties at end systole, is coupled to arterial mechanical properties and predicts the extent of subsequent interdialytic systolic blood pressure rise relative to weight gain. Therefore, ventricular stiffness at end systole is a determinant of the enhanced volume sensitivity of blood pressure in hemodialysis patients.
Key Words: renal dialysis • hypertension, renovascular • blood pressure • blood volume • arteriosclerosis • cardiac function
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Hypertension is present in
80% to 90% of patients by the time chronic renal failure progresses to end-stage renal disease (ESRD) and is one of the major risk factors that contributes to the development of cardiovascular disease in patients undergoing dialysis.1,2 A rational approach to this issue necessitates insight into the mechanisms that underlie hypertension in renal failure.1
Volume expansion has long been considered the most important factor in the development and maintenance of hypertension in ESRD.1,2 It is well accepted that hypertension can be controlled by adequate dialysis and the maintenance of dry weight in 85% to 90% of dialysis patients. In one center in Tassin, France, almost 98% of the patients were normotensive while receiving no medication by long, slow dialysis.3,4 In contrast, 50% of hypertensive patients without renal function impairment are considered salt-sensitive and respond to diuretic therapy alone.5,6 Thus, it is obvious that the sensitivity of blood pressure change to volume expansion or removal in patients with ESRD is increased compared with hypertensive patients with normal renal function. The mechanisms by which volume expansion leads to an elevation in blood pressure are conventionally attributed to an increase in cardiac output and an inappropriately high systemic vascular resistance.1
We have demonstrated that arterial stiffening with age is matched by ventricular systolic stiffening, indexed by the end-systolic pressure-volume relation (ie, left ventricular end-systolic elastance, Ees).7 The two effects contribute to elevating systolic blood pressure (SBP) sensitivity to acutely altered chamber filling7 and might explain the enhanced pressure lability with diuretics and postural shifts in the elderly. Although Ees implies the sensitivity of SBP to acute volume reduction, it is unknown whether Ees also predicts changes in SBP with long-term volume change. On the other hand, increased arterial stiffness as a hemodynamic overload with consequential and parallel cardiac and vascular adaptations in patients with ESRD has been recognized.8 The structural and functional alterations of large arteries might contribute to the pathogenesis of left ventricular hypertrophy.8 However, it is not known whether the arterial stiffening in ESRD is coupled to cardiac systolic stiffening and whether the combined stiffening contributes to enhanced volume sensitivity in ESRD.
Thus, the objectives of the present study were to investigate whether (1) Ees predicts long-term volume dependency of SBP and (2) Ees, as an index of ventricular mechanical properties at end systole, is coupled to arterial mechanical properties in ESRD patients undergoing regular hemodialysis. We hypothesized that the arterial stiffening observed in ESRD patients is coupled to left ventricular systolic stiffening and that this combined ventriculoarterial stiffening can enhance the volume sensitivity of arterial blood pressure, similar to that observed in normal aging.7 The observed large variability in volume sensitivity in ESRD9,10 might partly be explained by the variability in the extent of ventriculovascular stiffening in these patients.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Study Population
A total of 115 patients with ESRD who had been undergoing regular hemodialysis for at least 6 months were enrolled (Table 1). They were prescribed 3 g dietary salt per day and had not been receiving any antihypertensive medication or lipid-lowering therapy for at least 2 months. All patients received 4-hour dialysis sessions 3 times weekly with a dialysate containing 140 mEq/ sodium.11
|
Cardiac and Vascular Structure and Function
The interdialysis supine brachial artery SBP and diastolic blood pressure (DBP) were measured with an oscillometric device. The following dimensions were measured online from the 2D, guided M-mode echocardiograph: aortic root diameter, left atrial dimension, left ventricular internal dimension at end systole and end diastole, and thickness of the interventricular septum and left ventricular posterior wall. Ejection fraction and left ventricular mass were calculated. Stroke volume (SV) was measured by pulse wave Doppler echocardiography. Cardiac index was calculated from SV and heart rate.
Ees is a key determinant of cardiac systolic function and ventricular-arterial interaction not susceptible to loading changes.12 Ees was estimated with a recently proposed single-beat method.13,14 The right common carotid artery diameter at diastole and the intimal-medial thickness of the posterior wall were measured from the 2D echocardiographic images.11
Various aspects of the function of large arteries were indexed by the trunk pulse wave velocity,11 aortic compliance (AC), effective arterial elastance (Ea), and carotid augmentation index (AI).11 AC was the ratio of SV to pulse pressure.15 Ea was the ratio of end-systolic pressure (Pes) to SV.16 Additionally, peripheral vascular resistance was calculated as the ratio of mean blood pressure to cardiac output.
Hydration Status
Inferior vena cava diameter was measured by 2D-guided M-mode echocardiography.17 Total body water and fat-free mass were measured by the multifrequency bioimpedance method.18
Volume Sensitivity of Arterial Pressure
Predialysis (final interdialysis blood pressure) and postdialysis (initial interdialysis blood pressure) seated blood pressure and body weight were recorded for 25 consecutive dialysis sessions with a mercury sphygmomanometer and a beam scale.10 For each interdialysis session, the ratio of blood pressure gain per body weight gain was calculated. The average of all positive ratios (average, 16 ratios) during the 25 sessions represented the observed volume sensitivity index (Vinx) for the individual. Patients were grouped as having high or low volume sensitivity when their values of Vinx were in the upper or lower tertile, respectively.
In a subset of 34 patients, ambulatory blood pressure was monitored for 48 hours including the entire interdialysis period and one dialysis session within 1 week after the cardiovascular examination was performed. The device was programmed to measure blood pressure at 20-minute intervals during the daytime (7 AM to 11 PM) and at 30-minute intervals during the nighttime (11 PM to 7 AM).
Statistical Analysis
Data are presented as mean±SD. Correlations between interdialytic weight gain and blood pressure change and between Vinx and the parameters of cardiovascular hemodynamics were performed with simple and multiple linear regression analyses. Between-group comparisons were performed with unpaired Student t tests. Statistical significance was set at the level of P<0.05.
An expanded Methods section can be found in an online supplement available at http://www.hypertensionaha.org.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Volume Dependency of Interdialytic Blood Pressure Change
Significant volume dependency of blood pressure was observed in these patients. The interdialytic weight gain, averaged from all 25 hemodialysis sessions, was correlated significantly with the average percent change in SBP (r=0.35, P=0.001), mean blood pressure (r=0.32, P=0.003), and DBP (r=0.25, P=0.018). Similarly, the average interdialytic weight gain per fat-free mass was also correlated significantly with average percent change in SBP (r=0.45, P<0.001), mean blood pressure (r=0.42, P<0.001), and DBP (r=0.36, P=0.001). The observed Vinx ranged from 1.84 to 20.56 mm Hg/kg. The distribution of Vinx across the study population is displayed in Figure 1.
|
Ees and Volume Dependency of SBP
The estimated Ees at baseline could predict the subsequently observed values of Vinx: Vinx=(1.17xEes)+6.4 (r=0.34, P<0.001; Figure 2). The correlation between Ees and Vinx persisted after age and SBP were accounted for (P=0.034).
|
Coupled Cardiac and Arterial Stiffness
Ees was significantly correlated with Ea (r=0.48, P<0.001), pulse wave velocity (r=0.30, P=0.001), AI (r=0.31, P<0.001), and AC (r=-0.49, P<0.001).
Volume Sensitivity and Hemodynamics
Vinx was not correlated with any blood pressure values measured in either the interdialysis or intradialysis period. In the subgroup of 34 patients who had undergone 48-hour ambulatory blood pressure monitoring, predialysis SBP was correlated significantly with 48-hour mean SBP (r=0.59, P<0.001), 48-hour daytime SBP (r=0.62, P<0.001), and 48-hour nighttime SBP (r=0.49, P<0.001). Similarly, postdialysis SBP was correlated with 48-hour mean SBP, daytime SBP, and nighttime SBP (r=0.56, 0.58, and 0.46, respectively; all P<0.001). However, Vinx was not correlated with any of the ambulatory blood pressure measurements.
Except for Ees, Vinx was not correlated with any of the cardiac function variables. On the other hand, Vinx was correlated significantly with most of the vascular function variables, including AC (r=-0.22, P=0.016), Ea (r=0.24, P=0.009), AI (r=0.21, P=0.025), and total peripheral resistance (TPR) (r=0.29, P=0.019). In a stepwise multiple regression analysis including Ees, AC, Ea, AI, and TPR as independent variables, only Ees remained significantly associated with the dependent variable Vinx (P=0.001).
Volume Sensitivity and Hydration Status
Vinx was correlated significantly with total body water (r=-0.32, P<0.001), percent total body water (r=-0.22, P<0.001), and fat-free mass (r=-0.32, P=0.001) but not with other hydration status variables. After controlling for age and SBP, total body water (P=0.001) and fat free mass (P=0.001) remained significantly related to Vinx. In a stepwise multiple regression analysis including Ees, total body water, and fat-free mass as independent variables, Ees (P=0.001) and fat-free mass (P=0.002) remained significantly associated with the dependent variable Vinx.
Comparison Between High and Low Volume–Sensitivity Groups
The high volume–sensitivity group had significantly higher predialysis SBPs (P<0.05) than did the low volume–sensitivity group (Table 2). However, both groups appeared to have similar ambulatory blood pressure profiles recorded for a consecutive 48 hours (Table 2). Although both groups had comparable cardiovascular structures, the high-sensitivity group appeared to have stiffer left ventricular chamber properties, as reflected by significantly greater Ees (P<0.001; Table 3). The high-sensitivity group also had stiffer large arteries, as reflected by the significantly greater AI (P=0.005) and Ea (P=0.013), and significantly lower AC (P=0.03). TPR was also higher in the high-sensitivity group compared with the low-sensitivity group (P=0.002). The high volume–sensitivity group had significantly smaller interdialysis body weight (P=0.015), body surface area (P=0.014), fat-free mass (P=0.003), and total body water (P=0.004; Table 4).
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
In this study, we have demonstrated that the interdialytic blood pressure rise is directly related to the interdialytic weight gain and that the volume factor is important in blood pressure regulation in hemodialysis patients. With a novel, totally noninvasive technique, we have demonstrated for the first time that Ees predicts the extent of the subsequent interdialytic SBP rise relative to weight gain and therefore is a determinant of chronic volume dependency of SBP in ESRD patients. The association between Ees and Vinx is independent of age, interdialysis SBP, and hydration status. Because Ees is a measure of left ventricular mechanical properties at end systole and is coupled to arterial mechanical properties, our results support the hypothesis that the enhanced volume sensitivity of blood pressure in ESRD patients is due partly to the coupled systolic-ventricular and vascular stiffening in these patients.
Ventricular-Vascular Coupling in ESRD
The arterial system in ESRD patients undergoes structural remodeling similar to changes with aging and is characterized by diffuse dilation, hypertrophy, and stiffening of the aorta and major arteries.8,19–22 Arterial stiffening results in increased left ventricular systolic stress and left ventricular hypertrophy.23 Previous studies have demonstrated that the alteration of arterial structure and function is coupled to cardiac structural adaptation, mainly left ventricular hypertrophy.8 Our data broaden the established cardiac and arterial interactions in ESRD by demonstrating the association between Ees and various arterial functional parameters. Ees is traditionally considered a measure of contractility, as it directly varies in response to inotropic agents and is less influenced by volume and resistance load.24 However, conceptually, Ees is also a measure of chamber stiffness at end systole. Ees depends on both active contraction and on diastolic and passive structural factors.7,25 The association of Ees with Ea and other arterial stiffness indices indicates that the arterial stiffening in ESRD is also coupled to left ventricular systolic stiffening, similar to that observed in normal aging.7 Combined ventricular-vascular stiffening could potentially have important consequences on the cardiac response to varied filling volume, because a stiff heart-arterial system generates a greater systolic pressure change for a given change in ventricular volume. By varying loading acutely with occlusion of the inferior vena cava during cardiac catheterization, we have demonstrated that aging-related systolic-ventricular and vascular stiffening contributes to the greater sensitivity of blood pressure to volume change.7
Volume Factor and Pressor System
The role of volume overload in the pathogenesis of hypertension in hemodialysis patients was questioned recently, and the role of pressor systems was emphasized.1,2,9 TPR has been shown to be substantially greater in hypertensive compared with normotensive ESRD patients.11,26 The reasons for such inappropriate elevations of peripheral vascular resistance in hypertensive ESRD patients are unclear. Although the importance of the volume factor in blood pressure regulation in hemodialysis patients has been clearly demonstrated in the present study, our results also support the presence of the pressor systems and their possible contribution to the observed volume sensitivity: TPR was significantly related to Vinx, and patients with high volume sensitivity had significantly higher TPR than did patients with low volume sensitivity. Our results suggest that with similar volume gain in the interdialysis period, blood pressure rises more in patients with higher TPR.
Characteristics of ESRD Patients With High and Low Volume Sensitivity
Patients with high volume sensitivity appeared to be thinner than their low volume–sensitivity counterparts. Both groups had similar cardiovascular structures, but the volume-sensitive patients had distinctly stiffer large arteries and left ventricles at end systole. The high volume–sensitivity patients had higher SBP at predialysis, yet their 48-hour ambulatory blood pressure profiles were similar to those of the low volume–sensitivity patients, implying greater blood pressure lability owing to the demonstrated cardiovascular stiffening in the former.
The volume sensitivity of blood pressure has been previously assessed with different techniques. The volume factor has been manipulated or estimated by using salt loading,27 interdialytic weight change,10 bioelectric impedance analysis to measure predialysis total body water28 or postdialysis extracellular fluid volume,29 ultrasound for determining the inferior vena cava diameter,17 or intradialytic decrease in plasma volume calculated from predialysis and postdialysis total plasma protein concentrations.30 In the present study, we used interdialytic weight gain to estimate the interdialytic fluid accumulation, which did not assess postdialysis volume status.17 However, we complemented our methods with measurements of total body water and inferior vena cava diameter during the interdialytic period, which suggested that postdialysis volume overload should have been minimal in our patients. Furthermore, the demonstration of significant volume sensitivity of blood pressure supports the adequacy of the current methodology in the present study.
In addition to predialysis and postdialysis blood pressures, ambulatory blood pressure has also been used to assess volume sensitivity in previous studies.28 Although ambulatory blood pressure is considered the "gold standard" for diagnosing hypertension and monitoring treatment in ESRD patients,31 a 2-week, averaged, dialysis-unit blood pressure (6 measurements) either before or after dialysis, can provide a reliable guide to the presence of hypertension or its control.31 On the other hand, the predictive power of average monthly values (12 measurements) of predialysis blood pressure for left ventricular mass is not inferior to that of ambulatory blood pressure monitoring.32 In the present study, we averaged blood pressure measurements for 25 dialysis sessions to demonstrate the volume dependency of interdialytic blood pressure change. Furthermore, to calculate Vinx, we purposefully eliminated those sessions when the initial blood pressure was lower than the final blood pressure, so that Vinx would be less affected by factors other than volume that also modulate the variability in blood pressure values over the intradialytic and interdialytic intervals.1,33 Although intradialysis ambulatory blood pressure monitoring data could be used to calculate Vinx, the Vinx by ambulatory blood pressure monitoring from one dialysis session would not necessarily be superior to the Vinx by routine predialysis and postdialysis blood pressures from an average of 16 sessions (across a period of 2 months). Monitoring for an entire interdialysis and/or intradialysis session measures the blood pressure variation for that session only and does not account for the significant variability among different sessions.34 On the other hand, although the variability and measurement errors for predialysis and postdialysis blood pressure can attenuate or even mask potential associations with other variables, increasing the number of measurements might reduce the attenuation of association.10
Mechanisms other than volume are involved in blood pressure regulation in patients with uremia, such as the renin-angiotensin system, adrenergic activity, renal vasodilators, and other potential, novel effector mechanisms.1 In this study, we did not measure baroreceptor function or plasma norepinephrine levels, and we had only one measurement of plasma rennin activity during the interdialysis day. Therefore, we were unable to explore the interaction of volume sensitivity with other mechanisms in blood pressure regulation. However, the demonstration of increased volume sensitivity caused by cardiovascular stiffening in ESRD patients is not contradictory, and might be complementary, to those established and potential mechanisms. For example, orthostatic changes in blood pressure in the elderly are related to decreased baroreceptor sensitivity.35 However, cardiovascular stiffening with the resultant volume sensitivity in the elderly might also contribute to postural hypotension, probably through the relative hypovolemia with the pooling of blood volume in the lower body on assuming the upright posture. In addition, it has been shown that decreased arterial compliance might be responsible for the declined baroreceptor function in the elderly.36
Perspectives
This study demonstrates the possible role of cardiovascular stiffening in blood pressure regulation in patients with ESRD. Future studies are required to explore the potential benefit of intervention on cardiovascular stiffening in these patients.
|
Acknowledgments |
|---|
This work was supported in part by grants from the National Science Council (grant Nos. NSC 88-2314-B-075-074 and NSC 89-2314-B-010-016) and intramural grants from the Taipei Veterans General Hospital, Taiwan, ROC (grant Nos. VGH 87-306, VGH 88-304, and VGH 89-257).
|
Footnotes |
|---|
Part of this study was presented at the 72nd Annual Scientific Sessions of the American Heart Association; November 7–10, 1999; Atlanta, Georgia.
Received February 4, 2003; first decision February 19, 2003; accepted June 30, 2003.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Ritz E, Koomans HA. New insights into mechanisms of blood pressure regulation in patients with uraemia. Nephrol Dial Transplant. 1996; 11 (suppl 2): 52–59.[Abstract]
2. Mailloux LU, Haley WE. Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis. 1998; 32: 705–719.[Medline] [Order article via Infotrieve]
3. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41: 1286–1291.[Medline] [Order article via Infotrieve]
4. Chazot C, Charra B, Vo VC, Jean G, Vanel T, Calemard E, Terrat JC, Ruffet M, Laurent G. The Janus-faced aspect of "dry weight." Nephrol Dial Transplant. 1999; 14: 121–124.
5. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996; 27: 481–490.
6. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med. 1995; 122: 223–226.
7. Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. Coupled systolic-ventricular and vascular stiffening with age implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol. 1998; 32: 1221–1227.
8. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996; 50: 600–608.[Medline] [Order article via Infotrieve]
9. Luik AJ, Kooman JP, Leunissen KM. Hypertension in haemodialysis patients: is it only hypervolaemia? Nephrol Dial Transplant. 1997; 12: 1557–1560.[Medline] [Order article via Infotrieve]
10. Ventura JE, Sposito M. Volume sensitivity of blood pressure in end-stage renal disease. Nephrol Dial Transplant. 1997; 12: 485–491.
11. Lin YP, Chen CH, Yu WC, Hsu TL, Ding PY, Yang WC. Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients. Kidney Int. 2002; 62: 1828–1838.[CrossRef][Medline] [Order article via Infotrieve]
12. Kass DA, Maughan WL. From " Emax" to pressure-volume relations: a broader view. Circulation. 1988; 77: 1203–1212.
13. Senzaki H, Chen CH, Kass DA. Single-beat estimation of end-systolic pressure-volume relation in humans: a new method with the potential for noninvasive application. Circulation. 1996; 94: 2497–2506.
14. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, Kawaguchi M, Kass DA. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol. 2001; 38: 2028–2034.
15. Randall OS, Westerhof N, Van Den Bos GC, Alexander B. Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance. J Hypertens. 1986; 4 (suppl): s293–s296.
16. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol Heart Circ Physiol. 1983; 245: H773–H780.
17. Cheriex EC, Leunissen KML, Janssen JHA, Mooy JMV, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for the estimation of dry weight in haemodialysis patients. Nephrol Dial Transplant. 1989; 4: 563–568.
18. De Lorenzo A, Andreoli A, Matthie J, Withers P. Predicting body cell mass with bioimpedance by using theoretical methods: a technological review. J Appl Physiol. 1997; 82: 1542–1558.
19. Kawagishi T, Nishizawa Y, Konishi. T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H. High-resolution ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995; 48: 820–826.[Medline] [Order article via Infotrieve]
20. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997; 51: 1678–1695.[Medline] [Order article via Infotrieve]
21. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM. Aortic and large artery compliance in end-stage renal failure. Kidney Int. 1990; 37: 137–142.[Medline] [Order article via Infotrieve]
22. Barenbrock M, Spieker C, Laske V, Heidenreich S, Hohage H, Bachmann J, Hoeks APG, Rahn KH. Studies of the vessel wall properties in hemodialysis patients. Kidney Int. 1994; 45: 1397–1400.[Medline] [Order article via Infotrieve]
23. O’Rourke MF. Mechanical principles in arterial disease. Hypertension. 1995; 26: 2–9.
24. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res. 1973; 32: 314–322.
25. Suga H, Hisano R, Goto Y, Yamada O. Normalization of end-systolic pressure-volume relation and Emax of different sized hearts. Jpn Circ J. 1984; 48: 136–143.[Medline] [Order article via Infotrieve]
26. Kim KE, Onesti G, Schwartz AB, Chinitz JL, Swartz C. Hemodynamics of hypertension in chronic end-stage renal disease. Circulation. 1972; 46: 456–464.
27. Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure: a comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985; 7: 714–721.
28. Dionisio P, Valenti M, Bergia R, Caramello E, Stramignoni E, Berto IM, Pellerey M, Bajardi P. Influence of the hydration state on blood pressure values in a group of patients on regular maintenance hemodialysis. Blood Purif. 1997; 15: 25–33.[Medline] [Order article via Infotrieve]
29. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino FJ, Leypoldt JK, Leunissen KM, Laurent G, Bergstrom J. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant. 1999; 14: 369–375.
30. Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002; 61: 266–275.[CrossRef][Medline] [Order article via Infotrieve]
31. Agarwal R, Lewis RR. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 2001; 60: 1982–1989.[CrossRef][Medline] [Order article via Infotrieve]
32. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cottini E, Giacone G, Malatino L. Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens. 1999; 17: 1751–1758.[CrossRef][Medline] [Order article via Infotrieve]
33. Raj DS, Vincent B, Simpson K, Sato E, Jones KL, Welbourne TC, Levi M, Shah V, Blandon P, Zager P, Robbins RA. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int. 2002; 61: 697–704.[CrossRef][Medline] [Order article via Infotrieve]
34. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis. 2000; 36: 983–990.[CrossRef][Medline] [Order article via Infotrieve]
35. Hopson JR, Rea RF, Kienzle MG. Alterations in reflex function contributing to syncope: orthostatic hypotension, carotid sinus hypersensitivity and drug-induced dysfunction. Herz. 1993; 18: 164–174.[Medline] [Order article via Infotrieve]
36. Monahan KD, Tanaka H, Dinenno FA, Seals DR. Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensitivity. Circulation. 2001; 104: 1627–1632.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||